; charset=UTF-8 7bit Pharmalot Pfizer On The Hook For Off-Label Generic Use Posted: 22 Mar 2008 08:15 AM CDT A Philadelphia judge has ruled that Pfizer may have a legal duty for money spent on the generic version of Neuronton, according to The Legal Intelligencer. The brand-name drug, you may recall, was approved as a supplemental med for epilepsy, but Pfizer and Warner-Lambert - which Pfizer acquired - paid a $430 million fine four years a go for off-label marketing. And the generic, known as gabapentin, was made by other manufacturers. The legal question presented in a Pfizer motion for partial summary judgment was whether a drugmaker, which negligently or intentionally perpetrates a fraud upon the medical community by the off-label marketing of its name-brand drug, can be held responsible for money paid to other drug companies that make the generic equivalent of the name-brand drug, wrote Philadelphia Common Pleas Judge Mark Bernstein. And so he let stand claims of negligent negligence and intentional concerning the generic that was made by other manufacturers. The judge wrote that it was foreseeable that marketing Neurontin for off-label use would increase the demand for a generic version, according to the Intelligencer. Pfizer estimated that Neurontin would lose between 65 percent to 95 percent of its market once Neurontin patents expired, so Pfizer proposed marketing its own generic, Bernstein noted. I believe its the first opinion in the country that expressly says that a brand-name manufacturer can be liable for the money spent on drugs manufactured by a third-party manufacturer, plaintiffs attorney John Weston tells the paper. There are not a huge number of cases that address this. Jere Beasley Made Alabama A Judicial Hellhole Posted: 21 Mar 2008 02:54 PM CDT Jere Beasley was nearly broke and looking for work after getting whipped in a race for governor 30 years ago. Since then, the rural Alabama lawyer has re-emerged as a powerhouse plaintiffs attorney whose firm counts more than $20 billion in verdicts and settlements, the Associated Press writes. One of the Souths latest tort kings, Beasleys success against corporate giants has made him a constant target of business groups, with Karl Rove once putting him in Republican political cross-hairs. Beasley is one of the most successful personal injury lawyers in the game, Darren McKinney of the American Tort Reform Association, tells the AP. Although, he adds this came with a dubious distinction: Theres no question Beasley was integral in winning for Alabama a reputation most people in Alabama rather it not have won - that is a judicial hellhole. Beasleys firm helped negotiate the $4.8 billion settlement with Merck over Vioxx and a $700 million settlement over pollution from an old Monsanto PCB plant. He also helped the state of Alabama win an $11.9 billion verdict against Exxon Mobil and last months $215 million verdict against AstraZeneca (back story). Up next month is trial of a drug-pricing fraud suit against Glaxo and Novartis, with about 70 similar suits in the wings. Wanna read more? Look here -- You are buy onlined to email updates from "Pharmalot." To stop receiving these emails, you may unsubcribe now If you prefer to purchase via postal mail, write to: Pharmalot, c/o FeedBurner, 549 W Randolph, Chicago IL USA 60661 This Email Delivery powered by FeedBurner. ; charset=UTF-8 7bit Pharmalot h1 a:hover ! important;} tr td div ul { } tr td div blockquote { 6px solid #dadada; } tr td div li { } tr td a:link, tr td a:visited, tr td a:active { } img {border:none;} Pharmalot Pfizer On The Hook For Off-Label Generic Use Posted: 22 Mar 2008 08:15 AM CDT A Philadelphia judge has ruled that Pfizer may have a legal duty for money spent on the generic version of Neuronton, according to The Legal Intelligencer. The brand-name drug, you may recall, was approved as a supplemental med for epilepsy, but Pfizer and Warner-Lambert - which Pfizer acquired - paid a $430 million fine four years a go for off-label marketing. And the generic, known as gabapentin, was made by other manufacturers. The legal question presented in a Pfizer motion for partial summary judgment was whether a drugmaker, which or intentionally perpetrates a fraud upon the medical by the off-label marketing of its name-brand drug, can be held responsible for money paid to other drug companies that make the generic equivalent of the name-brand drug, wrote Philadelphia Common Pleas Judge Mark Bernstein. And so he let stand claims of negligent negligence and intentional concerning the generic that was made by other manufacturers. The judge wrote that it was foreseeable that marketing Neurontin for off-label use would increase the demand for a generic version, according to the Intelligencer. Pfizer estimated that Neurontin would lose between 65 percent to 95 percent of its market once Neurontin patents expired, so Pfizer proposed marketing its own generic, Bernstein noted. “I believe it’s the first opinion in the country that expressly says that a brand-name manufacturer can be liable for the money spent on drugs manufactured by a third-party plaintiffs attorney John Weston tells the paper. “There are not a huge number of cases that address this.” Jere Beasley Made Alabama A ‘Judicial Hellhole’ Posted: 21 Mar 2008 02:54 PM CDT Jere Beasley was nearly broke and looking for work after getting whipped in a race for governor 30 years ago. Since then, the rural Alabama lawyer has re-emerged as a powerhouse attorney whose firm counts more than $20 billion in verdicts and settlements, the Associated Press writes. One of the South’s latest tort kings, Beasley’s success against corporate giants has made him a constant target of business groups, with Karl Rove once putting him in Republican political cross-hairs. “Beasley is one of the most successful personal injury lawyers in the game,” Darren McKinney of the American Tort Reform Association, tells the AP. Although, he adds this came with a dubious distinction: no question Beasley was integral in winning for Alabama a reputation most people in Alabama rather it not have won - that is a judicial Beasley’s firm helped negotiate the $4.8 billion settlement with Merck over Vioxx and a $700 million settlement over pollution from an old Monsanto PCB plant. He also helped the state of Alabama win an $11.9 billion verdict against Exxon Mobil and last month’s $215 million verdict against AstraZeneca (back story). Up next month is trial of a drug-pricing fraud suit against Glaxo and Novartis, with about 70 similar suits in the wings. Wanna read more? Look here… You are buy onlined to email updates from Pharmalot To stop receiving these emails, you may purchase now.Email Delivery powered by FeedBurner Inbox too full? Buy online to the feed version of Pharmalot in a feed reader. If you prefer to purchase via postal mail, write to: Pharmalot, c/o FeedBurner, 20 W Kinzie, 9th Floor, Chicago IL USA 60610

... Back to listing 6

... Back to article 1050 | SITEMAP | Next to article 1052 ...

We would like to express our gratitude to all those who are kindly providing this unique content, especially to:

office@a3ides.com
olga@bemobile.md
tirlik@brainchildhunter.com
office@bemobile.md
sharuha@causeni.info
info@webconsulting.md
irina.gorea@bemobile.md
office@milieukontakt.nl
igor.romanyuk@bemobile.com.ua
yuri.sekretar@olympia.net.ua
info@tophost.md
webmoldova@yahoo.com
admin@bemobile.md
webmaster@bemobile.md
emil@a3ides.com
olea@bemobile.md
yuri.sekretar@bemobile.com.ua
contact@a3ides.com
info@a3ides.com
vitaliy.lozovskiy@bemobile.md
drugg83@yahoo.com
rector@usm.md
gaugash@usm.md
acad.rudic@mail.md
acadrudic@yahoo.com
veaceslav.vasilache@gmail.com
s.bakker@milieukontakt.nl
katea.melnicenco@gmail.com
mkoe.moldova@vox.md
musteata@doctor.com
renat.buga@ase.md
s.molenkamp@milieukontakt.nl
si_problemme@mail.ru
willem.tjebbe.oostenbrink@planet.nl

Tag cloud:

Alabama, generic, against, Beasley, off-label, billion, marketing, Neurontin, million, Pharmalot, settlement, percent, Philadelphia, generic,, question, name-brand, Posted:, manufacturers., brand-name, attorney, Intelligencer., according, verdict, purchase, plaintiffs, version, concerning, negligence, intentional, negligent,

Similar listing on: